Exeo Capital expects Chemical Process Technologies to generate $10m in revenues by 2022
The South African investment fund targets animal pharmaceuticals in southern Africa and Latin America.
17/05/2022 at 14h37, by Africa Business+
“Our core markets are in Southern Africa, and we expect good export growth in existing markets in South America with the additional capacity we will create in the wake of our majority stake in Chemical Process Technologies (CPT).
Recommended articles
Health
28/11/2023 at 19h15, by Africa Business+
Katrine DiBona, Novo Nordisk: “We aim to serve four million African patients by 2026”
The Danish group’s corporate vice president, global public affairs and sustainability, described the...
New technologies
30/11/2022 at 18h47, by Africa Business+
Morocco : MedZ and Ewane approach Europeans to extend technopoles
The two Moroccan branches of CDG Développement are negotiating with several financiers to expand their...
Health
25/04/2022 at 12h00, by Africa Business+
BluePeak invests in Africure Pharmaceutical and targets two other companies
The young alternative asset management firm based in London, Nairobi and Tunis is to provide mezzanine...
Health
18/01/2022 at 16h22, by Africa Business+
Frank Roger Djoko Bansi promoted to head Eurapharma’s Uniphart in Togo
The Cameroonian, who has a doctorate in pharmacy, was appointed to head the Eurapharma subsidiary in...
Health
06/01/2022 at 16h31, by Africa Business+
Gregory Rockson’s mPharma to raise $100m
The Ghanaian start-up has just closed a $35 million round of financing, which will only be an intermediary...
Health
03/11/2021 at 17h49, by Africa Business+
Sahel Pharma Industrie launches pharmaceutical manufacturing project
According to Africa Business+ sources, the Burkinabe pharmaceutical group has raised CFAF 10.5 billion...